COMPANY PROFILE · UPDATED 01 AUG 2026

Maze Therapeutics

Translating genetic insights into therapeutic innovations · Harnessing the potential of modern human genetics to treat disease.

mazetx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2018
Headcount: 139
Open roles: 11
Last raised: Post Ipo Equity · Sign in to view

TECH STACK

How Maze Therapeutics builds

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Maze Therapeutics

View all 11 open roles →

FUNDING

Capital raised

Total raised

$646,000,000

Investors

Gv Andreessen Horowitz General CatalystAlexandria Venture InvestmentsArch Venture PartnersCasdin CapitalCity Hill VenturesDeep Track CapitalDriehaus Capital ManagementForesite CapitalFrazier Life SciencesJanus CapitalLogos CapitalMatrix Capital ManagementMoore Strategic VenturesNS InvestmentTerra Magnum Capital PartnersThird Rock VenturesWoodline Partners

Funding rounds

Post Ipo Equity
$150MSep 11, 2025
IPO
UndisclosedJan 1, 2025
Series D
Deep Track Capital, Frazier Life Sciences, Janus Capital, Logos Capital
$115MDec 2, 2024
Series Unknown
Matrix Capital Management, Andreessen Horowitz, Moore Strategic Ventures, Casdin Capital, General Catalyst, Driehaus Capital Management, City Hill Ventures, Woodline Partners, Foresite Capital, NS Investment, Terra Magnum Capital Partners
$190MJan 9, 2022
Series A
Arch Venture Partners, Third Rock Ventures, GV, Casdin Capital, Foresite Capital, Alexandria Venture Investments
$191MFeb 27, 2019

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery AI Infrastructure

Investors

Gv Andreessen Horowitz General Catalyst

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

Maze Therapeutics offices

Loading map…

South San Francisco, CA171 Oyster Point Blvd suite 300